Coronavirus Disease-2019 Pandemic: Hopes Ride High on Targeting Known Drugs against Unkown.

Mahalmani, Vidya M; Mahendru, Dhruv; Sarma, Phulen; Prakash, Ajay; Medhi, Bikash

Mahalmani, Vidya M; Mahendru, Dhruv; Sarma, Phulen; Prakash, Ajay; Medhi, Bikash.

Mahalmani VM; Department of Pharmacology, PGIMER, Chandigarh, India.
Mahendru D; Department of Pharmacology, PGIMER, Chandigarh, India.
Sarma P; Department of Pharmacology, PGIMER, Chandigarh, India.
Prakash A; Department of Pharmacology, PGIMER, Chandigarh, India.
Medhi B; Department of Pharmacology, PGIMER, Chandigarh, India.

Indian J Pharmacol ; 52(2): 75-78, 2020.

Article in English | MEDLINE | ID: covidwho-611649

Subject(s)

Chloroquine/therapeutic use; Coronavirus Infections/drug therapy; Hydroxychloroquine/therapeutic use; Pneumonia, Viral/drug therapy; Angiotensin-Converting Enzyme Inhibitors/adverse effects; Angiotensin-Converting Enzyme Inhibitors/therapeutic use; Antimalarials/therapeutic use; COVID-19; Chloroquine/adverse effects; Coronavirus Infections/prevention & control; Drug Delivery Systems; Humans; Hydroxychloroquine/adverse effects; Ibuprofen/adverse effects; Ibuprofen/therapeutic use; Pandemics/prevention & control; Pneumonia, Viral/prevention & control; Treatment Outcome; COVID-19 Drug Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Chloroquine / Coronavirus Infections / Hydroxychloroquine Type of study: Prognostic study Limits: Humans Language: English Journal: Indian J Pharmacol Year: 2020 Document Type: Article Affiliation country: Ijp.IJP_309_20

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google